Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Human Chymotrypsin Oral Powder for Improving Mucosal Visibility Before Gastroscopy (Phase II)
CTR20244461Phase 2Completed
- Sponsor
- Healthgen Biotech
- Start
- Dec 2024
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Recombinant Human Chymotrypsin, sponsored by Healthgen Biotech. Started Dec 2024; status: completed.
02
Drugs
Recombinant Human Chymotrypsin
Beyond the preview
Go deeper on CTR20244461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244461.